Open AccessA phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors
Author(s) -
Hanna K. Sanoff,
Janine M. Davies,
Christine M. Walko,
William Irvin,
Larry W. Buie,
Kimberly L. Keller,
Anastasia Ivanova,
WingKeung Chiu,
Bert H. O’Neil,
Thomas E. Stinchcombe,
E. Claire Dees
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/4edx-db25
Subject(s) - erlotinib , refractory (planetary science) , medicine , oncology , pharmacology , dermatology , materials science , cancer , epidermal growth factor receptor , metallurgy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom